Excited to share our new paper by Tom and published in @Nature detailing how disruption of mitochondrial protein trafficking causes anti-tumor immunity via the MHC class I antigen presentation pathway, synergizing strongly with immune checkpoint blockade
rdcu.be/ccn7advy9Bpa
rdcu.be/ccn7advy9Bpa